SolasCure, a biotechnology company that is dedicated to working towards filling the current market gap in debridement – the removal of necrotic tissue to encourage healing – and healing solutions for chronic wounds has announced a partnership with the US Army’s Institute of Surgical Research (USAISR).

The HFX iq, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages artificial intelligence technology to manage chronic pain, has received CE mark certification in Europe.

Pharmarole.com

Welcome to the final edition of 2024: Pharmafocus December.

Page 13 – improving the patient experience: insights from uganda, the uk and us

Earlier in November, the Chalmers University of Technology in Sweden published the results of a study demonstrating that resistant bacteria, when paired with material equipped with antibacterial peptides, can regain susceptibility to antibiotics.

Leading global healthcare company Novo Nordisk, who is a top contender for the industry's first $1trn valuation after the launch of its groundbreaking diabetes drug Ozempic in 2017, is set to introduce a promising new weight-loss treatment called CagriSema.

Biotech company Cytomos has announced this month that it has raised £5m to scale up the production of its unique cell analysis technology.

Salarysurvey.pharmarole.com

Msea.pharmatimes.com

Advance Tests, committed to enhancing diagnostic accessibility and advancing early disease detection, announced the exclusive UK launch of LucentAD complete.